<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208607/" ref="ordinalpos=3573&amp;ncbi_uid=6820193&amp;link_uid=PMC4208607" image-link="/pmc/articles/PMC4208607/figure/f2/" class="imagepopup">FIG. 2..  From: Mitophagy Is Required for Acute Cardioprotection by Simvastatin. </a></div><br /><div class="p4l_captionBody"><b>Statins attenuate Akt/mTOR signaling. (A)</b> Representative western blots of Akt/mTOR signaling pathway proteins from HL-1 cells treated with vehicle (DMSO, solid bars) or simvastatin (statin, hashed bars) as indicated. <b>(B)</b> Quantitation of results shown in <b>(A)</b>. n=3 per group; experiments were performed at least three times. *p-value&lt;0.05. <b>(C)</b> Representative western blots of Akt/mTOR signaling pathway proteins in DMSO or statin-treated mouse hearts. n=4 mice per condition. <b>(D)</b> Quantitation of results shown in <b>(C)</b>. Akt, protein kinase B; mTOR, mammalian target of rapamycin.</div></div>